Codeine Market Size, Competitors, Trends & Forecast to 2032

The codeine market is navigating a transitional landscape shaped by evolving clinical standards, heightened regulatory scrutiny, and operational complexity. Senior leaders across the value chain are prioritizing safety, supply continuity, and compliance to safeguard long-term viability and address the shifting needs of healthcare providers and patients.

Market Snapshot: Growth and Outlook for the Codeine Market

The codeine market advanced from USD 4.31 billion in 2025 to USD 4.50 billion in 2026, with strong momentum projected at a compound annual growth rate (CAGR) of 4.79% through 2032 to reach USD 5.98 billion. This measured, sustained expansion reflects ongoing therapeutic demand, innovation in formulations, and intensifying regulatory vigilance, positioning codeine as a critical class within controlled-substance pharmaceutical markets.

Scope & Segmentation of the Global Codeine Market

Product Chemistry: Codeine Hydrochloride, Codeine Phosphate, Codeine Sulfate, and Combination Products, each tailored for stability, dissolution, and population-specific pharmacokinetics.
Formulation Types: Syrups (including sugar-based and sugar-free), immediate- and extended-release tablets, and injectable formats supporting a full spectrum of clinical needs from pediatric adherence to acute-care protocols.
Clinical Applications: Pain management and cough suppression, with delineated treatment strategies for adult and pediatric segments and acute versus chronic scenarios.
Distribution Channels: Hospital pharmacy, online pharmacy, and retail pharmacy, each with distinct compliance, access, and dispensing requirements.
End-User Environments: Clinics, home care providers, and hospital settings, necessitating tailored supply, education, and support structures.
Regional Focus: Americas, Europe, Middle East & Africa, and Asia-Pacific, reflecting regulatory, clinical, and infrastructure-specific variations impacting commercial planning.
Supply-Chain Technologies: Serialization, cold- and controlled-substance handling, inventory analytics, and telehealth-enabled prescribing safeguards.

Key Takeaways for Senior Decision-Makers

Clinical shifts emphasize individualized codeine prescribing, requiring portfolios that address both safety and efficacy across diverse patient cohorts.
Regulatory oversight is intensifying globally, driving companies to fortify pharmacovigilance, update labeling, and enhance real-time supply tracking.
Distribution channels are increasingly omni-channel, blending traditional pharmacies with digital platforms, which heightens requirements for traceability and compliance.
Formulation innovation is a response to both prescriber caution and evolving patient preferences, notably in extended-release, sugar-free, and pediatric-friendly solutions.
Operational resilience demands supplier diversification, risk-mitigation agreements, and robust quality assurance to withstand pricing and sourcing volatility.
Cross-regional disparities in regulation and procurement necessitate adaptive strategies, harmonized documentation, and region-specific portfolio adjustments.

Tariff Impact on Codeine Supply and Operations

Tariff actions introduced in 2025 substantially altered input costs, sourcing strategies, and downstream logistics for codeine manufacturers and distributors. Companies responded by expanding dual-sourcing, accelerating supplier qualification, and reassessing supply chain contracts to share increased expenses with partners. Distribution networks restructured warehousing and routing to offset new cross-border costs, prompting renewed emphasis on operational resilience and risk management. These shifts led to tighter inventory controls at end-user sites and heightened demand for transparency in pricing and contractual negotiations.

Methodology & Data Sources

This report synthesizes primary interviews with clinicians, supply-chain and regulatory experts, and market stakeholders, complemented by secondary regulatory and pharmacovigilance reviews. Cross-validation ensures the reliability of findings, and an iterative analytical process addresses diverse stakeholder perspectives.

Why This Codeine Market Report Matters

Enables senior leaders to refine supply-chain planning, ensuring both regulatory compliance and uninterrupted patient access in dynamic global markets.
Informs commercial and R&D strategy through actionable segmentation insights, enabling targeted innovation across products and channels.
Supports decision-making with transparent assessment of recent policy impacts and operational challenges affecting sectoral competitiveness.

Primary Keyword: Codeine Market

The codeine market requires coordinated action across manufacturing, regulation, and commercialization to respond to complex clinical and compliance environments. Strategic alignment enables organizations to manage regulatory risk, optimize product portfolios, and maintain trust with both prescribers and patients.

Conclusion

The codeine market’s trajectory will be defined by agility in compliance, resilient operations, and ongoing formulation innovation. Stakeholders who coordinate across supply, regulatory, and commercial functions will be positioned to sustain clinical value and navigate market complexity.

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates.
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025

8. Codeine Market, by Product Type

8.1. Codeine Hydrochloride
8.2. Codeine Phosphate
8.3. Codeine Sulfate
8.4. Combination Products

9. Codeine Market, by Form

9.1. Injection
9.1.1. Intramuscular
9.1.2. Intravenous
9.2. Syrup
9.2.1. Sugar Based
9.2.2. Sugar Free
9.3. Tablet
9.3.1. Extended Release
9.3.2. Immediate Release

10. Codeine Market, by Application

10.1. Cough Suppression
10.2. Pain Management
10.2.1. Acute Pain
10.2.2. Chronic Pain

11. Codeine Market, by Distribution Channel

11.1. Hospital Pharmacy
11.2. Online Pharmacy
11.3. Retail Pharmacy

12. Codeine Market, by End User

12.1. Clinics
12.2. Home Care
12.3. Hospitals

13. Codeine Market, by Region

13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific

14. Codeine Market, by Group

14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO

15. Codeine Market, by Country

15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea

16. United States Codeine Market
17. China Codeine Market

18. Competitive Landscape

18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Abbott Laboratories
18.6. Accord Healthcare by Intas Pharmaceuticals
18.7. Advik Pharma
18.8. AstraEureka Pharmaceuticals
18.9. Bristol Laboratories Limited
18.10. Crescent Pharma Limited
18.11. Johnson Matthey Plc
18.12. Noramco, Inc.
18.13. Omnica Laboratories
18.14. Pfizer Inc.
18.15. Professional Compounding Centers of America, Inc.
18.16. SANOFI WINTHROP INDUSTRIE
18.17. Sun Pharmaceutical Industries Ltd.
18.18. Teva Pharmaceutical Industries Ltd.

List of Figures

FIGURE 1. GLOBAL CODEINE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL CODEINE MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL CODEINE MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL CODEINE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL CODEINE MARKET SIZE, BY FORM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL CODEINE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL CODEINE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL CODEINE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL CODEINE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL CODEINE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES CODEINE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA CODEINE MARKET SIZE, 2018-2032 (USD MILLION)

List of Tables

TABLE 1. GLOBAL CODEINE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL CODEINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL CODEINE MARKET SIZE, BY CODEINE HYDROCHLORIDE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL CODEINE MARKET SIZE, BY CODEINE HYDROCHLORIDE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL CODEINE MARKET SIZE, BY CODEINE HYDROCHLORIDE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL CODEINE MARKET SIZE, BY CODEINE PHOSPHATE, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL CODEINE MARKET SIZE, BY CODEINE PHOSPHATE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL CODEINE MARKET SIZE, BY CODEINE PHOSPHATE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL CODEINE MARKET SIZE, BY CODEINE SULFATE, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL CODEINE MARKET SIZE, BY CODEINE SULFATE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL CODEINE MARKET SIZE, BY CODEINE SULFATE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL CODEINE MARKET SIZE, BY COMBINATION PRODUCTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL CODEINE MARKET SIZE, BY COMBINATION PRODUCTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL CODEINE MARKET SIZE, BY COMBINATION PRODUCTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL CODEINE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL CODEINE MARKET SIZE, BY INJECTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL CODEINE MARKET SIZE, BY INJECTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL CODEINE MARKET SIZE, BY INJECTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL CODEINE MARKET SIZE, BY INJECTION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL CODEINE MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL CODEINE MARKET SIZE, BY INTRAMUSCULAR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL CODEINE MARKET SIZE, BY INTRAMUSCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL CODEINE MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL CODEINE MARKET SIZE, BY INTRAVENOUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL CODEINE MARKET SIZE, BY INTRAVENOUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL CODEINE MARKET SIZE, BY SYRUP, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL CODEINE MARKET SIZE, BY SYRUP, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL CODEINE MARKET SIZE, BY SYRUP, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL CODEINE MARKET SIZE, BY SYRUP, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL CODEINE MARKET SIZE, BY SUGAR BASED, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL CODEINE MARKET SIZE, BY SUGAR BASED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL CODEINE MARKET SIZE, BY SUGAR BASED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL CODEINE MARKET SIZE, BY SUGAR FREE, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL CODEINE MARKET SIZE, BY SUGAR FREE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL CODEINE MARKET SIZE, BY SUGAR FREE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL CODEINE MARKET SIZE, BY TABLET, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL CODEINE MARKET SIZE, BY TABLET, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL CODEINE MARKET SIZE, BY TABLET, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL CODEINE MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL CODEINE MARKET SIZE, BY EXTENDED RELEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL CODEINE MARKET SIZE, BY EXTENDED RELEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL CODEINE MARKET SIZE, BY EXTENDED RELEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL CODEINE MARKET SIZE, BY IMMEDIATE RELEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL CODEINE MARKET SIZE, BY IMMEDIATE RELEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL CODEINE MARKET SIZE, BY IMMEDIATE RELEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL CODEINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL CODEINE MARKET SIZE, BY COUGH SUPPRESSION, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL CODEINE MARKET SIZE, BY COUGH SUPPRESSION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL CODEINE MARKET SIZE, BY COUGH SUPPRESSION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL CODEINE MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL CODEINE MARKET SIZE, BY PAIN MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL CODEINE MARKET SIZE, BY PAIN MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL CODEINE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL CODEINE MARKET SIZE, BY ACUTE PAIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL CODEINE MARKET SIZE, BY ACUTE PAIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL CODEINE MARKET SIZE, BY ACUTE PAIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL CODEINE MARKET SIZE, BY CHRONIC PAIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL CODEINE MARKET SIZE, BY CHRONIC PAIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL CODEINE MARKET SIZE, BY CHRONIC PAIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL CODEINE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL CODEINE MARKET SIZE, BY HOSPITAL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL CODEINE MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL CODEINE MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL CODEINE MARKET SIZE, BY ONLINE PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL CODEINE MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL CODEINE MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL CODEINE MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL CODEINE MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL CODEINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL CODEINE MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL CODEINE MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL CODEINE MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL CODEINE MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL CODEINE MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL CODEINE MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL CODEINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL CODEINE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL CODEINE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL CODEINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. AMERICAS CODEINE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 82. AMERICAS CODEINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 83. AMERICAS CODEINE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 84. AMERICAS CODEINE MARKET SIZE, BY INJECTION, 2018-2032 (USD MILLION)
TABLE 85. AMERICAS CODEINE MARKET SIZE, BY SYRUP, 2018-2032 (USD MILLION)
TABLE 86. AMERICAS CODEINE MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 87. AMERICAS CODEINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 88. AMERICAS CODEINE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 89. AMERICAS CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 90. AMERICAS CODEINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 91. NORTH AMERICA CODEINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. NORTH AMERICA CODEINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 93. NORTH AMERICA CODEINE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 94. NORTH AMERICA CODEINE MARKET SIZE, BY INJECTION, 2018-2032 (USD MILLION)
TABLE 95. NORTH AMERICA CODEINE MARKET SIZE, BY SYRUP, 2018-2032 (USD MILLION)
TABLE 96. NORTH AMERICA CODEINE MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 97. NORTH AMERICA CODEINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 98. NORTH AMERICA CODEINE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 99. NORTH AMERICA CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 100. NORTH AMERICA CODEINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 101. LATIN AMERICA CODEINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 102. LATIN AMERICA CODEINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 103. LATIN AMERICA CODEINE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 104. LATIN AMERICA CODEINE MARKET SIZE, BY INJECTION, 2018-2032 (USD MILLION)
TABLE 105. LATIN AMERICA CODEINE MARKET SIZE, BY SYRUP, 2018-2032 (USD MILLION)
TABLE 106. LATIN AMERICA CODEINE MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 107. LATIN AMERICA CODEINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 108. LATIN AMERICA CODEINE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 109. LATIN AMERICA CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 110. LATIN AMERICA CODEINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA CODEINE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA CODEINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA CODEINE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA CODEINE MARKET SIZE, BY INJECTION, 2018-2032 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA CODEINE MARKET SIZE, BY SYRUP, 2018-2032 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA CODEINE MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA CODEINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA CODEINE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA CODEINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 121. EUROPE CODEINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 122. EUROPE CODEINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 123. EUROPE CODEINE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 124. EUROPE CODEINE MARKET SIZE, BY INJECTION, 2018-2032 (USD MILLION)
TABLE 125. EUROPE CODEINE MARKET SIZE, BY SYRUP, 2018-2032 (USD MILLION)
TABLE 126. EUROPE CODEINE MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 127. EUROPE CODEINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 128. EUROPE CODEINE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 129. EUROPE CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 130. EUROPE CODEINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 131. MIDDLE EAST CODEINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 132. MIDDLE EAST CODEINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 133. MIDDLE EAST CODEINE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 134. MIDDLE EAST CODEINE MARKET SIZE, BY INJECTION, 2018-2032 (USD MILLION)
TABLE 135. MIDDLE EAST CODEINE MARKET SIZE, BY SYRUP, 2018-2032 (USD MILLION)
TABLE 136. MIDDLE EAST CODEINE MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 137. MIDDLE EAST CODEINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 138. MIDDLE EAST CODEINE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 139. MIDDLE EAST CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 140. MIDDLE EAST CODEINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 141. AFRICA CODEINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 142. AFRICA CODEINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 143. AFRICA CODEINE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 144. AFRICA CODEINE MARKET SIZE, BY INJECTION, 2018-2032 (USD MILLION)
TABLE 145. AFRICA CODEINE MARKET SIZE, BY SYRUP, 2018-2032 (USD MILLION)
TABLE 146. AFRICA CODEINE MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 147. AFRICA CODEINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 148. AFRICA CODEINE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 149. AFRICA CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 150. AFRICA CODEINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 151. ASIA-PACIFIC CODEINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 152. ASIA-PACIFIC CODEINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 153. ASIA-PACIFIC CODEINE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 154. ASIA-PACIFIC CODEINE MARKET SIZE, BY INJECTION, 2018-2032 (USD MILLION)
TABLE 155. ASIA-PACIFIC CODEINE MARKET SIZE, BY SYRUP, 2018-2032 (USD MILLION)
TABLE 156. ASIA-PACIFIC CODEINE MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 157. ASIA-PACIFIC CODEINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 158. ASIA-PACIFIC CODEINE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 159. ASIA-PACIFIC CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 160. ASIA-PACIFIC CODEINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 161. GLOBAL CODEINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 162. ASEAN CODEINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 163. ASEAN CODEINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 164. ASEAN CODEINE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 165. ASEAN CODEINE MARKET SIZE, BY INJECTION, 2018-2032 (USD MILLION)
TABLE 166. ASEAN CODEINE MARKET SIZE, BY SYRUP, 2018-2032 (USD MILLION)
TABLE 167. ASEAN CODEINE MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 168. ASEAN CODEINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 169. ASEAN CODEINE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 170. ASEAN CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 171. ASEAN CODEINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 172. GCC CODEINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 173. GCC CODEINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 174. GCC CODEINE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 175. GCC CODEINE MARKET SIZE, BY INJECTION, 2018-2032 (USD MILLION)
TABLE 176. GCC CODEINE MARKET SIZE, BY SYRUP, 2018-2032 (USD MILLION)
TABLE 177. GCC CODEINE MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 178. GCC CODEINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 179. GCC CODEINE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 180. GCC CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 181. GCC CODEINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 182. EUROPEAN UNION CODEINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 183. EUROPEAN UNION CODEINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 184. EUROPEAN UNION CODEINE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 185. EUROPEAN UNION CODEINE MARKET SIZE, BY INJECTION, 2018-2032 (USD MILLION)
TABLE 186. EUROPEAN UNION CODEINE MARKET SIZE, BY SYRUP, 2018-2032 (USD MILLION)
TABLE 187. EUROPEAN UNION CODEINE MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 188. EUROPEAN UNION CODEINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 189. EUROPEAN UNION CODEINE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 190. EUROPEAN UNION CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 191. EUROPEAN UNION CODEINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 192. BRICS CODEINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 193. BRICS CODEINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 194. BRICS CODEINE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 195. BRICS CODEINE MARKET SIZE, BY INJECTION, 2018-2032 (USD MILLION)
TABLE 196. BRICS CODEINE MARKET SIZE, BY SYRUP, 2018-2032 (USD MILLION)
TABLE 197. BRICS CODEINE MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 198. BRICS CODEINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 199. BRICS CODEINE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 200. BRICS CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 201. BRICS CODEINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 202. G7 CODEINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 203. G7 CODEINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 204. G7 CODEINE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 205. G7 CODEINE MARKET SIZE, BY INJECTION, 2018-2032 (USD MILLION)
TABLE 206. G7 CODEINE MARKET SIZE, BY SYRUP, 2018-2032 (USD MILLION)
TABLE 207. G7 CODEINE MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 208. G7 CODEINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 209. G7 CODEINE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 210. G7 CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 211. G7 CODEINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 212. NATO CODEINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 213. NATO CODEINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 214. NATO CODEINE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 215. NATO CODEINE MARKET SIZE, BY INJECTION, 2018-2032 (USD MILLION)
TABLE 216. NATO CODEINE MARKET SIZE, BY SYRUP, 2018-2032 (USD MILLION)
TABLE 217. NATO CODEINE MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 218. NATO CODEINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 219. NATO CODEINE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 220. NATO CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 221. NATO CODEINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 222. GLOBAL CODEINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 223. UNITED STATES CODEINE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 224. UNITED STATES CODEINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 225. UNITED STATES CODEINE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 226. UNITED STATES CODEINE MARKET SIZE, BY INJECTION, 2018-2032 (USD MILLION)
TABLE 227. UNITED STATES CODEINE MARKET SIZE, BY SYRUP, 2018-2032 (USD MILLION)
TABLE 228. UNITED STATES CODEINE MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 229. UNITED STATES CODEINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 230. UNITED STATES CODEINE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 231. UNITED STATES CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 232. UNITED STATES CODEINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 233. CHINA CODEINE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 234. CHINA CODEINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 235. CHINA CODEINE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 236. CHINA CODEINE MARKET SIZE, BY INJECTION, 2018-2032 (USD MILLION)
TABLE 237. CHINA CODEINE MARKET SIZE, BY SYRUP, 2018-2032 (USD MILLION)
TABLE 238. CHINA CODEINE MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 239. CHINA CODEINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 240. CHINA CODEINE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 241. CHINA CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 242. CHINA CODEINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Codeine market report include:

Abbott Laboratories
Accord Healthcare by Intas Pharmaceuticals
Advik Pharma
AstraEureka Pharmaceuticals
Bristol Laboratories Limited
Crescent Pharma Limited
Johnson Matthey Plc
Noramco, Inc.
Omnica Laboratories
Pfizer Inc.
Professional Compounding Centers of America, Inc.
SANOFI WINTHROP INDUSTRIE
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.

Table Information

Report Attribute	Details
No. of Pages	184
Published	January 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 4.5 Billion
Forecasted Market Value ( USD ) by 2032	$ 5.98 Billion
Compound Annual Growth Rate	4.7%
Regions Covered	Global
No. of Companies Mentioned	15

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3450EUR$3,939USD£2,994GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3721EUR$4,249USD£3,230GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5044EUR$5,759USD£4,378GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€6104EUR$6,969USD£5,298GBP

Codeine Market - Global Forecast 2026-2032

Market Snapshot: Growth and Outlook for the Codeine Market

Scope & Segmentation of the Global Codeine Market

Key Takeaways for Senior Decision-Makers

Tariff Impact on Codeine Supply and Operations

Methodology & Data Sources

Why This Codeine Market Report Matters

Primary Keyword: Codeine Market

Conclusion

Table of Contents

Companies Mentioned

Table Information

Market Snapshot: Growth and Outlook for the Codeine Market

Scope & Segmentation of the Global Codeine Market

Key Takeaways for Senior Decision-Makers

Tariff Impact on Codeine Supply and Operations

Methodology & Data Sources

Why This Codeine Market Report Matters

Primary Keyword: Codeine Market

Conclusion

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Codeine (CAS 76-57-3) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

Codeine Sulfate (CAS 1420-53-7) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

Opioids Market Report 2025

Opioid Analgesics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Analgesics Market - Global Forecast 2026-2032

About the Codeine Market